Christopher Peetz - 03 Jul 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
President and CEO, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
03 Jul 2023
Transactions value $
-$141,005
Form type
4
Filing time
05 Jul 2023, 19:30:23 UTC
Previous filing
19 May 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$141K -5.5K -4.55% $25.65 115K 03 Jul 2023 Direct F1
holding MIRM Common Stock 202K 03 Jul 2023 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.